Arrhythmias & electrophysiology

A Phenotype-Enhanced Variant Classification Framework to Decrease the Burden of Variants of Uncertain Significance in Type 2 Long QT Syndrome

JACC Clin ElectrophysiolPublished Retrospective cohort study

Authors' conclusion

Phenotype-guided variant adjudication significantly decreased the VUS burden of LQT2 case-derived KCNH2 missense variants from 2 LQTS specialty centers.

Study context

Population
Unique KCNH2 missense variants in patients with clinically suspected LQT2
Participants
209 unique missense variants
Exposure
Phenotype-enhanced American College of Medical Genetics (ACMG) variant re-adjudication vs initial genetic test report classification
Outcome
VUS burden
Methodological details2 long QT syndrome (LQTS) specialty centers
  • 2 LQTS specialty centers

Main finding

As reported in the abstract

VUS burden among unique KCNH2 missense variants
Variants of uncertain significance (VUS) on initial genetic test reports
69/209 (33%)
VUS burden overall, initial vs after PE-ACMG adjudication
69 of 209 (33%) to 9/209 (4%; P < 0.0001)
VUS upgraded to pathogenic after PE-ACMG adjudication
31/69 variants (45%)
VUS upgraded to likely pathogenic
18 (26%)
VUS downgraded to benign
11 (16%)
Variants remaining VUS
9 of 69 variants (13%)

Observational data: associations, not effects.

Further findings

Reclassification of the 69 initial VUS after PE-ACMG

Upgraded to pathogenic
31/69 (45%)
Upgraded to likely pathogenic
18 (26%)
Downgraded to benign
11 (16%)
Remained VUS
9 of 69 (13%)

Schwartz score in patients with a VUS

Mean Schwartz score
3.6
Score over 3.5
41 patients (29%)

Original publication

A Phenotype-Enhanced Variant Classification Framework to Decrease the Burden of Variants of Uncertain Significance in Type 2 Long QT Syndrome. JACC Clin Electrophysiol. Published 24 November 2025. doi:10.1016/j.jacep.2025.10.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.